Electronic cigarette use in lung cancer patients
肺癌患者使用电子烟
基本信息
- 批准号:10768042
- 负责人:
- 金额:$ 18.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAdvocateAffectAreaAuthorization documentationBehavioral ResearchCOVID-19Cancer PatientCancer SurvivorCigaretteClinicalClinical ResearchClinical TrialsCohort StudiesComprehensive Cancer CenterDataData CollectionDevelopmentDiagnosisElectronic Nicotine Delivery SystemsElectronic cigaretteEnvironmentEpidemiologistExcisionFosteringFundingFutureGeneral PopulationGoalsGuidelinesHead CancerHealthHealth BenefitInstitutionInterruptionInterventionIntervention StudiesInvestigationMalignant NeoplasmsMalignant neoplasm of lungMarketingMeasuresMentorsMetabolismNational Comprehensive Cancer NetworkNeck CancerObservational StudyOhioOperative Surgical ProceduresOutcomePatient RecruitmentsPatientsPerioperative complicationPoliciesPopulationPositioning AttributeProfessional OrganizationsPublic HealthQuality of lifeQuasi-experimentReportingRequest for ProposalsResearchResearch ActivityResearch DesignResearch MethodologyResearch PersonnelResearch Project GrantsSafetySample SizeSmokeSmokerSmokingSmoking Cessation InterventionSurgeonSurgical complicationSymptomsTobaccoTobacco-Related CarcinomaToxic effectTrainingTreatment-related toxicityUnited StatesUnited States Food and Drug AdministrationUniversitiesauthoritycancer epidemiologycancer survivalcareer developmentchemotherapycigarette smokingcohortcombustible cigarettecoronavirus diseasedesigneditorialelectronic cigarette useevidence baseexperienceexposure to cigarette smokefollow-uphospital utilizationimprovedmembernovelpatient populationrandomized trialresponsesafety assessmentskillssmoking cessationsoundstandard of caresymptomatologytobacco controltobacco productstobacco regulatory sciencetooltreatment as usualtreatment guidelines
项目摘要
TITLE: Electronic Cigarette Use in Head, Neck, and Lung Cancer Patients
PROJECT SUMMARY/ABSTRACT
The overall goal of this proposal is to facilitate Dr. Theodore Brasky’s development into an established and
independent investigator for tobacco control. For this research, he will focus on cancer patients and the impact
of electronic cigarettes (e-cigs) on cigarette smoking, quitting, and health outcomes. It is established that
cigarette smoking adversely affects the cancer patient in many ways. E-cigs have the potential to reduce
cigarette smoke exposures, related toxicities, and foster smoking cessation. However, almost no research
exists to substantiate this hypothesis. Dr. Brasky is a cancer epidemiologist and member of the Ohio State
University Comprehensive Cancer Center (OSUCCC) with considerable expertise in the analysis and
interpretation of longitudinal data. Due to a strong institutional environment, he has been participating in
various tobacco-focused research projects over the past several years. Excited by this, he wants to take
advantage of the extraordinary opportunities in tobacco control related to e-cigs. The proposed training plan
will enable him to obtain expertise and experience in tobacco research (e.g., coursework in tobacco regulatory
science), intervention studies (e.g., coursework in clinical research methods and translational behavioral
research), and primary data collection in complementary studies. This training will capitalize on the exceptional
institutional environment at OSU and an experienced mentor in tobacco control in Dr. Peter Shields, Deputy
Director of the OSUCCC. Herein, Dr. Brasky will address critical research gaps that will aid in the
understanding for the impact of e-cigs on the cancer patient generally, and specifically for the creation of sound
policy decisions by the Food and Drug Administration. This proposal requests a funded extension to complete
Dr. Brasky’s research goals due to significant COVID-19 related interruptions. The Specific Aims are to: 1)
analyze an observational cohort of 184 head, neck, and lung cancer patients and examine the associations of
e-cigs with smoking reduction, smoking cessation, quality of life, and treatment toxicities; and, 2) Evaluate
feasibility, acceptability, compliance, and safety of a pilot patient-choice trial of a pod-based e-cig versus
standard of care in 40 head, neck, and lung cancer patients planning to undergo surgical resection. These
complementary studies will be among the first to examine associations in patients with tobacco-related cancers
and will share assessment measures. Results from this research will yield critical data in order to provide
sound and evidence-based decisions on e-cigs.
标题:电子烟在头颈癌和肺癌患者中的使用
项目概要/摘要
该提案的总体目标是促进 Theodore Brasky 博士发展成为一个成熟的、
烟草控制独立调查员。在这项研究中,他将重点关注癌症患者及其影响
电子烟(e-cigs)对吸烟、戒烟和健康结果的影响。确定
吸烟在很多方面对癌症患者产生不利影响。电子烟有可能减少
香烟烟雾暴露、相关毒性并促进戒烟。但几乎没有研究
的存在就是为了证实这个假设。 Brasky 博士是一位癌症流行病学家,也是俄亥俄州立大学的成员
大学综合癌症中心 (OSUCCC) 在分析和治疗方面拥有丰富的专业知识
纵向数据的解释。由于强大的制度环境,他一直参与
过去几年各种以烟草为重点的研究项目。他对此感到兴奋,想要采取
利用与电子烟相关的烟草控制的绝佳机会。拟议的培训计划
将使他能够获得烟草研究方面的专业知识和经验(例如,烟草监管课程)
科学)、干预研究(例如临床研究方法和转化行为学课程)
研究),以及补充研究中的主要数据收集。此次培训将利用特殊的
俄勒冈州立大学 (OSU) 的制度环境以及副教授彼得·希尔兹 (Peter Shields) 博士在烟草控制方面经验丰富的导师
OSUCCC 主任。在此,布拉斯基博士将解决关键的研究空白,这将有助于
了解电子烟对癌症患者的总体影响,特别是对声音产生的影响
食品药品监督管理局的政策决定。该提案要求资助延期以完成
Brasky 博士的研究目标因与 COVID-19 相关的重大中断而中断。具体目标是:1)
分析了 184 名头颈癌和肺癌患者的观察队列,并检查了以下因素之间的关联:
电子烟具有减少吸烟、戒烟、提高生活质量和治疗毒性的作用;以及,2) 评估
基于烟弹的电子烟与患者选择试点试验的可行性、可接受性、合规性和安全性
40 名计划接受手术切除的头颈癌和肺癌患者的标准护理。这些
补充研究将是首批检查烟草相关癌症患者之间关系的研究之一
并将分享评估措施。这项研究的结果将产生关键数据,以便提供
关于电子烟的合理且基于证据的决策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theodore M. Brasky其他文献
Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.
患有和未患有癌症的女性与抗高血压药物使用相关的心血管结局:女性健康倡议的结果。
- DOI:
10.1634/theoncologist.2019-0977 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
K. Reding;A. Aragaki;Richard K. Cheng;A. Barac;S. Wassertheil;Jessica Chubak;Marian C. Limacher;W. Hundley;R. D’Agostino;Mara Z. Vitolins;Theodore M. Brasky;L. Habel;Eric J. Chow;R. Jackson;Chu Chen;A. Morgenroth;Wendy E. Barrington;M. Banegas;M. Barnhart;R. Chlebowski - 通讯作者:
R. Chlebowski
Associations of Cancer Patients' Demographic and Clinical Characteristics With Cannabis-Related Interest and Behaviors.
癌症患者的人口统计和临床特征与大麻相关兴趣和行为的关联。
- DOI:
10.1089/jpm.2023.0490 - 发表时间:
2023 - 期刊:
- 影响因子:2.8
- 作者:
N. Adley;Theodore M. Brasky;Sara R. Conroy;Alison M Newton;Jesse J. Plascak;S. Strassels;John L Hays;J. Krok - 通讯作者:
J. Krok
Prevalence of cannabis and medication use by indices of residential urbanicity and deprivation among Ohio cancer patients
- DOI:
10.1007/s10552-025-01972-x - 发表时间:
2025-02-12 - 期刊:
- 影响因子:2.100
- 作者:
Theodore M. Brasky;Shieun Lee;Bella McBride;Alison M. Newton;Ryan D. Baltic;Theodore L. Wagener;Sara Conroy;John L. Hays;Erin E. Stevens;Anita Adib;Jessica L. Krok-Schoen - 通讯作者:
Jessica L. Krok-Schoen
Theodore M. Brasky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theodore M. Brasky', 18)}}的其他基金
A pooled analysis of dietary long-chain omega-3 fatty acid intake and endometrial cancer risk
膳食长链 omega-3 脂肪酸摄入量与子宫内膜癌风险的汇总分析
- 批准号:
9376490 - 财政年份:2017
- 资助金额:
$ 18.66万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 18.66万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 18.66万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 18.66万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 18.66万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 18.66万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 18.66万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 18.66万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 18.66万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 18.66万 - 项目类别:














{{item.name}}会员




